Vivoryon Therapeutics N.V. (0R3M.L) LSE
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 39.13M |
| Enterprise Value | 33.62M |
| P/E Ratio | -4.98 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 21.67 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.57 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.62 |
| Return On Equity | -2.15 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -147,000 |
| EBITDA | -9.03M |
| Net Income | -8.85M |
| Diluted EPS | -0.33 |
Balance Sheet
| Total Cash | 2.45M |
| Total Cash/Share | 0.08 |
| Total Debt | 76,000 |
| Total Debt/Equity | 0.05 |
| Current Ratio | 4.56 |
| Book Value Per Share | 0.05 |
Price History
| 52-Week Change | -22.22 |
| 52-Week High | 19.4 |
| 52-Week Low | 0.5 |
| Moving Average 50 Days | 7.3 |
| Moving Average 200 Days | 9.93 |
Statistics
| Average Volume | 3,012 |
| Shares Outstanding | 29.57M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 256:251 |
| Last Split Date | October 24, 2019 |
AD
